title: Growth hormone treatment without a needle using the Preci-Jet 50 transjector.
abstract: A new delivery system (Preci-Jet 50) which administers growth hormone through the skin using high pressure and without a needle was evaluated. This device was inconvenient and painful compared with a pen injection system. The conclusion is that the Preci-Jet is not the panacea for solving the problem of compliance with subcutaneous growth hormone injections.
authors.affiliation: Great Ormond Street, Hospital for Children, NHS Trust, London.
authors.forename: P
authors.initials: P
authors.lastname: Bareille
authors.forename: M
authors.initials: M
authors.lastname: MacSwiney
authors.forename: A
authors.initials: A
authors.lastname: Albanese
authors.forename: C
authors.initials: C
authors.lastname: De Vile
authors.forename: R
authors.initials: R
authors.lastname: Stanhope
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D001768:Blister / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D018592:Cross-Over Studies; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000295:instrumentation*; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage* / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male
chemical_list: D013006:Growth Hormone